Because KMT2D-deficient HNSCC led to abnormal gene expression profiles to enhance glycolysis, we hypothesized that the glycolytic suppression may cause abnormal molecular and epigenetic changes in KMT2D-mutant HNSCC. Here, KMT2D is linked to head and neck squamous cell carcinoma.